Lead Sponsor

Boryung Pharmaceutical Co., Ltd

Age

19 - No limit years

Sex

ALL

Healthy Volunteers

No

•Male or female adults aged 19 or older
•Is to undergo elective surgery under general anesthesia
•Is planned to use rocuronium or vecuronium as an NMBA
•Is planned for extubation before/after being moved to the recovery room
•ASA physical status I - III
•Patients who have signed the informed consent after receiving information about the purpose and method of this study

•Has myasthenia gravis or Eaton-Lambert myasthenic syndrome
•Has hypersensitivity to ingredients of sugammadex, rocuronium, or vecuronium
•Has received an investigational product within 12 weeks from the study enrollment or has plans to participate in another clinical trial during the participation of this study.
•Other subjects who are considered inappropriate to participate in this study by the judgment of the investigator.